ENDOTAK RELIANCE G
Report
- Report Number
- 2124215-2014-13792
- Event Type
- Injury
- Date Received
- July 15, 2014
- Date of Event
- June 23, 2014
- Report Date
- November 6, 2019
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NVY
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
A PORTION OF THIS PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. IF ANALYSIS IS COMPLETED ON THIS PRODUCT, THIS REPORT WILL BE UPDATED AT THAT TIME.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED LOSS OF CAPTURE (LOC) DURING ATRIAL FLUTTER ABLATION PROCEDURE. THIS LEAD WAS PROGRAMMED TO OFF-ELECTROCAUTERY MODE FOR VOO PACING. A BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) CONSULTANT DISCUSSED THAT WHEN THE DEVICE IS IN ELECTROCAUTERY MODE AND SEE AN EXTERNAL POWER SOURCE, THE DEVICE PACES AT SUB THRESHOLD LEVELS. THE PATIENT WAS PACEMAKER DEPENDENT. ADDITIONAL INFORMATION RECEIVED FROM THE FIELD REPRESENTATIVE INDICATED THAT LOC RESULTED IN GREATER THAN TWO SECONDS OF ASYSTOLE. THIS LEAD WAS RE-PROGRAMMED AND REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
ADDITIONAL INFORMATION WAS RECEIVED THAT THIS LEAD WAS SURGICALLY ABANDONED DUE TO THE PREVIOUSLY REPORTED LOSS OF CAPTURE WITH ASYSTOLE. THIS LEAD WAS SEVERED AND A PORTION HAS BEEN RETURNED FOR ANALYSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 412175 | ENDOTAK RELIANCE G | IMPLANTABLE LEAD | NVY | BOSTON SCIENTIFIC CORPORATION | 0296 | 114738 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 99 YR | Hospitalization| R | 1290| N160| 4087| 4554| 4088| 0296 |